topotecan has been researched along with belinostat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chan, JV; Cheok, CF; Chng, WJ; Goh, BC; Hung, HT; Kannan, S; Koh, LYJ; Kong, LR; Lane, DP; Lau, JA; Le, TBU; Lee, M; Lim, CM; Mohamed Salleh, NAB; Ong, RW; Periyasamy, G; Tan, TZ; Thangavelu, M; Venkitaraman, A; Verma, CS; Wang, L | 1 |
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
2 other study(ies) available for topotecan and belinostat
Article | Year |
---|---|
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation.
Topics: Acetylation; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cisplatin; Codon; Epigenesis, Genetic; Gain of Function Mutation; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Mice, SCID; Models, Biological; Mutant Proteins; Mutation; Neoplasms; NF-kappa B; Nucleotide Motifs; Poly(ADP-ribose) Polymerases; Protein Binding; Protein Isoforms; Sulfonamides; Topotecan; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases; Xenograft Model Antitumor Assays | 2020 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |